Tag: Route 92 Medical
Route 92 gains EU and MDSAP certification for its neurovascular product...
Route 92 Medical announced today that it has obtained CE-mark approval under the EU Medical Device Regulation (MDR) 2017/745 for its innovative line of...
Route 92 announces US$50 million Series F extension equity financing
Route 92 Medical has announced a new US$50 million extension to its previously announced, oversubscribed Series F financing, bringing the total raised to US$82...
Route 92 Medical announces commercial launch of FreeClimb 88 catheter system
Route 92 Medical today announced the commercial launch of the FreeClimb 88 catheter system comprising the FreeClimb 88 catheter and the Tenzing 8 delivery...
Route 92 recalls catheter due to distal-tip separation at proximal marker...
Route 92 Medical is recalling specific lots of its products containing the Tenzing 7 delivery catheters due to multiple instances of distal-tip separation at...
Route 92 announces US FDA 510(k) clearance for FreeClimb 54 reperfusion...
Route 92 Medical has today announced receipt of US Food and Drug Administration (FDA) 510(k) clearance for the FreeClimb 54 reperfusion system, comprised of...
Route 92 completes enrolment in 250-patient SUMMIT MAX trial
Route 92 Medical has today announced the completion of enrolment in the 250-patient SUMMIT MAX clinical trial evaluating the safety and effectiveness of its...
Route 92 announces 100th patent for its neurovascular intervention portfolio
Route 92 Medical has announced the company’s 100th global issued patent for its innovative neurovascular intervention product portfolio, as per a press release. The...
Route 92 raises more than US$31 million in oversubscribed Series F...
Route 92 Medical has announced it has raised more than US$31 million in a Series F financing round to accelerate the commercial adoption of...
Route 92 announces positive clinical findings with Tenzing 7 delivery catheter
Route 92 Medical has announced new results from a multicentre clinical study evaluating the efficacy, safety and efficiency of the Tenzing 7 delivery catheter as a...
Route 92 Medical announces appointment of Jonathan Kennedy as chief financial...
Route 92 Medical has announced the appointment of Jonathan Kennedy to the role of chief financial officer. In this role, Kennedy will be responsible...
Route 92 announces publication of first-in-human study featuring FreeClimb 70 reperfusion...
Route 92 Medical has today announced the publication of a retrospective, first-in-human study featuring its FreeClimb 70 reperfusion system in the journal Interventional Neuroradiology....
Route 92 gains US FDA clearance for complete stroke treatment system
Route 92 Medical has today announced receipt of 510(k) clearance from the US Food and Drug Administration (FDA) for its FreeClimb 70 reperfusion system,...
Route 92 announces 80th patent for Monopoint operating platform
Route 92 Medical has today announced the issuance of the company’s 80th global patent for its Monopoint operating platform. Route 92 claims this is...
Route 92 Medical announces expansion to new manufacturing site in Utah
Route 92 Medical has announced its expansion to a new high-volume manufacturing site in Salt Lake City, USA. This 40,000-square-foot site will allow Route...
Route 92’s Monopoint operating platform shows 82% first-pass effect in independent...
Route 92 Medical recently announced the publication of an investigator-initiated, multicentre SLIC (Super large-bore ingestion of clot) study of its proprietary Monopoint operating platform,...
Route 92 publishes data demonstrating 80% first-pass effect with novel thrombectomy...
Route 92 Medical has announced the publication of initial results from the SUMMIT NZ clinical trial—a single-arm, multicentre, prospective trial evaluating its proprietary Monopoint...
Route 92 Medical announces first patient enrolment in SUMMIT MAX pivotal...
Route 92 Medical has announced the first patient enrolment in its SUMMIT MAX clinical trial—a randomised, controlled, multicentre study to evaluate the performance of...
